Skip to content

H.R. 4626 · 118th Congress (2023–2025)

OTC Act of 2023

This bill requires the Food and Drug Administration (FDA) to issue guidance on the approval process for over-the-counter oral contraceptives so as to encourage drug manufacturers to submit applications for approval. The FDA must also evaluate (1) whether and to what extent consumers understand the labeling on oral contraceptives, and (2) whether the labeling could be improved.

Show official title

To encourage sponsors of oral contraceptive drugs to submit applications for the approval of such drugs as over-the-counter, and for other purposes.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to Health

This bill’s path

This is H.R. 4626’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Mariannette Miller-Meeks (R-IA-1)
Cosponsors
10 cosponsors

9 original · 1 later

10 R

  1. Rep. Stephanie I. Bice (R-OK-5)· Original · Jul 13, 2023
  2. Rep. Lori Chavez-DeRemer (R-OR-5)· Original · Jul 13, 2023
  3. Rep. Marjorie Taylor Greene (R-GA-14)· Original · Jul 13, 2023
  4. Rep. Diana Harshbarger (R-TN-1)· Original · Jul 13, 2023
  5. Rep. Young Kim (R-CA-40)· Original · Jul 13, 2023
  6. Rep. Jennifer A. Kiggans (R-VA-2)· Original · Jul 13, 2023
  7. Rep. Nancy Mace (R-SC-1)· Original · Jul 13, 2023
  8. Rep. Nicole Malliotakis (R-NY-11)· Original · Jul 13, 2023
  9. Rep. Maria Elvira Salazar (R-FL-27)· Original · Jul 13, 2023
  10. Rep. Ashley Hinson (R-IA-2)· Later · Sep 14, 2023
Policy area
Health
Subjects
  • Drug safety, medical device, and laboratory regulation
  • Family planning and birth control
  • Government information and archives
  • Government studies and investigations
  • Prescription drugs
  • Women's health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest
    ▸ 2 committee actions · Jul 13, 2023 – Jul 14, 2023
    1. Referred to committee

      Referred to the House Committee on Energy and Commerce.

      Sources
    2. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
  3. Expired

    Introduced → Referred to House Health → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred Jul 13, 2023
  2. HouseHealthReferred Jul 14, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (3)
  1. OTC Act of 2023

    Display title, Short title · Introduced in House

  2. Orally Taken Contraception Act of 2023

    Short title · Introduced in House

  3. To encourage sponsors of oral contraceptive drugs to submit applications for the approval of such drugs as over-the-counter, and for other purposes.

    Official title · Introduced in House